The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 456-462

  Markovitch, O ^a   Tepper, R ^a   Fishman, A ^a   Shapira, J ^a   Aviram, R ^a   Cohen, I ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

Endometrial pathology; Menopause; Tamoxifen; Ultrasonography

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOMETRIAL DISEASE; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PERFORMANCE; POLYP; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; SAMPLING; TRANSVAGINAL ECHOGRAPHY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TAMOXIFEN; UTERINE DISEASES;

EID: 9944253388     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.06.053     Document Type: Article

References (32)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992;339:1-71;71-85.
2. I. Cohen, D.J.D. Rosen, J. Shapira, M. Cordoba, S. Gilboa, and M.M. Altaras Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer Br. J. Obstet. Gynaecol. 100 1993 567 570
3. E. Lahti, G. Blanco, A. Kauppila, M. Apaja-Sarkkinen, P.J. Taskinen, and T. Laatikainen Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen Obstet. Gynecol. 81 1993 660 664
4. I. Cohen, D.J.D. Rosen, R. Tepper, M. Cordoba, S. Gilboa, and M.M. Altaras Ultrasonographic evaluation of the endometrium with correlation to endometrial sampling in postmenopausal patients treated with tamoxifen J. Ultrasound Med. 5 1993 275 280
5. C.A. Hulka, and D.A. Hall Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation AJR 160 1993 809 812
6. I. Cohen, D.J.D. Rosen, J. Shapira, M. Cordoba, S. Gilboa, and M.M. Altaras Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients Gynecol. Oncol. 52 1994 185 190
7. R.P. Kedar, T.H. Bourne, T.J. Powels, W.P. Collins, S.E. Ashley, and D.O. Cosgrove Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial Lancet 343 1994 1318 1321
8. C. Exacoustos, E. Zupi, B. Cangi, M. Chiartti, D. Arduini, and C. Ramanini Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound colour flow Doppler, hysteroscopic and histologic study Ultrasound Obstet. Gynecol. 6 1995 435 442
9. S. Cecchini, S. Ciatto, R. Bonardi, A. Mazzotta, G. Grazzini, and P. Pacini Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients with tamoxifen treatment Gynecol. Oncol. 60 1996 409 411
10. J.M. Pepper, O.A. Oyesnya, P.J. Dewart, A. Howel, and M.W. Seif Indices of differential endometria: myometrial growth may be used to improve reliability of detecting endometrial neoplasia in women on tamoxifen Ultrasound Obstet. Gynecol. 8 1996 408 411
11. L.E. Hann, C.S. Geiss, A.M. Bach, Y. Tao, H.J. Baum, and R.R. Barakat Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings AJR 168 1997 657 661
12. D. Timmerman, J. Deprest, T. Bourne, I. Van den Berghe, W.P. Collins, and I. Vergote A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen Am. J. Obstet. Gynecol. 179 1998 62 70
13. G. Bertelli, M. Venturini, L. Del Mastro, O. Garrone, M. Cosso, and C. Gustavio Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients Breast Cancer Res. Treat. 47 1998 41 46
14. C.D.B. Love, B.B. Muir, J.B. Scrimgeour, R.C.F. Leonard, P. Dillon, and J.M. Dixon Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening J. Clin. Oncol. 17 1999 2050 2054
15. M.J.E. Mourits, A.G.J. Van der Zee, P.H.B. Willemse, K.A. Ten Hoor, H. Hollema, and E.G.E. De Vries Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen Gynecol. Oncol. 73 1999 21 26
16. M.R. Tesoro, A.F. Borgida, N.A. MacLaurin, and C.M. Asuncion Transvaginal endometrial sonography in postmenopausal women taking tamoxifen Obstet. Gynecol. 93 1999 363 366
17. B. Gerber, A. Krause, H. Muller, T. Reimer, T. Kulz, and J. Makovitzky Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound J. Clin. Oncol. 18 2000 3464 3470
18. R. Liedman, B. Lindhal, E. Andolf, R. Willen, C. Ingvar, and J. Ranstam Discordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and direct biopsy in breast cancer patients treated with tamoxifen Anticancer Res. 20 2000 4889 4892
19. I.T. Katagiri, Y. Murata, R. Hamazoe, and K. Morita Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy J. Obstet. Gynecol. Res. 27 2001 141 145
20. L.E. Hann, E.M. Gretz, A.M. Bach, and S.M. Francis Sonohysterography for evaluation of the endometrium in women treated with tamoxifen AJR 177 2001 337 342
21. K. Fong, R. Kung, A. Lytwyn, M. Trudeau, W. Chapman, and P. Nuget Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen Radiology 220 2001 765 773
22. M. Vosse, F. Renard, M. Coibion, P. Neven, J.M. Nogaret, and D. Hertens Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring Eur. J. Obstet. Gynecol. Reprod. Biol. 101 2002 58 63
23. ACOG Committee Opin. Tamoxifen Endomet. Cancer vol. 232 2000 104 106
24. E. Anteby, S. Yagel, D. Zacut, Z. Palti, and D. Hochner-Celnikier False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen (Letter) Lancet 340 1992 433 434
25. S. Ciato, S. Cecchini, R. Bonardi, and G. Grozzini Ultrasonographic surveillance of endometrium in breast cancer patients on adjuvant tamoxifen Lancet 244 1994 60
26. J. Bo, R. Auslender, B. Pascal, E. Gutterman, and H. Abramovici Diagnostic pitfalls of ultrasonographic screening in women treated with tamoxifen J. Reprod. Med. 39 1994 674 678
27. S.R. Goldstein Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen Am. J. Obstet. Gynecol. 170 1994 447 451
28. E. Anteby, S. Yagel, and D. Hochner-Celnikier Unusual ultrasonographic appearance of the uterus in postmenopausal receiving tamoxifen (Letter) Am. J. Obstet. Gynecol. 172 1995 17
29. M. Franchi, F. Ghezzi, N. Donadello, F. Zanaboni, P. Beretta, and P. Bolis Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease Obstet. Gynecol. 93 1999 1004 1008
30. K. Nahari, R. Tepper, Y. Beyth, D. Flex, A. Figer, and I. Cohen Long-term transvaginal endometrial follow-up in postmenopausal breast cancer patients with tamoxifen treatment Gynecol. Oncol. 74 1999 222 226
31. I. Cohen, Y. Beyth, R. Azaria, D. Flex, A. Figer, and R. Tepper Ultrasonographic measurement of endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients Brit. J. Obstet. Gynecol. 107 2000 1083 1087
32. A. Decensi, V. Fontana, S. Bruno, C. Gustavino, B. Gotteschi, and A. Casta Effect of tamoxifen on endometrial proliferation J. Clin. Oncol. 14 1996 434 440